Watershed Private Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$436K Hold
1,734
0.12% 89
2026
Q1
$377K Sell
1,734
-118
-6% -$26.2K 0.12% 89
2025
Q4
$423K Buy
1,852
+800
+76% +$182K 0.13% 85
2025
Q3
$244K Buy
+1,052
New +$214K 0.08% 105
2025
Q2
Sell
-1,109
Closed -$232K 106
2025
Q1
$232K Buy
+1,109
New +$216K 0.09% 107
2024
Q4
Sell
-1,115
Closed -$220K 113
2024
Q3
$220K Buy
+1,115
New +$208K 0.09% 108
2024
Q2
Sell
-1,104
Closed -$201K 119
2024
Q1
$201K Buy
+1,104
New +$190K 0.09% 122

Other funds holding ABBV

Watershed Private Wealth's ABBV Position: Q2 2026 in Review

Watershed Private Wealth held its AbbVie (ABBV) position steady in Q2 2026 at 1,734 shares worth $436K. The position accounts for 0.12% of the portfolio, ranked #89.

Watershed Private Wealth first reported a position in ABBV in Q1 2024 and has held it in 7 quarters since. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Watershed Private Wealth held 1,734 shares of AbbVie worth $436K as of Q2 2026.
  • Watershed Private Wealth left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.12% of Watershed Private Wealth's portfolio in Q2 2026, its #89 holding.
  • Watershed Private Wealth first reported a position in AbbVie in Q1 2024 and has held it in 7 quarters since.
  • 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Watershed Private Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.